9 completed, 2 recruiting, 1 terminated. 4 Not applicable, 2 Phase 1, 2 Phase 2, 2 Phase 4, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 2, Recruiting 2 |
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
| Phase 4 | 2 | Completed 2 |
| Phase 3 | 1 | Terminated 1 |
Follow zaleplon: new trials by email Literature Review of zaleplon trials Research Report on zaleplon
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pilot Randomized Controlled Trial of a Social Network Intervention SONATA - Advanced Cancer, Older Adults (65 Years and Older) | Not applicable | Recruiting | University of Rochester | 70 | 2026-04-10 | 2026-07-07 |
| A Single Arm Pilot Trial of a Social Network Intervention SONATA - Cancer | Not applicable | Recruiting | University of Rochester | 330 | 2023-11-29 | 2026-09-10 |
| Cerebral MRI During Sleep Zaleplon, Natural Sleep - Sleep | Completed | University of California, San Diego | 11 | 2017-10-01 | 2019-03-14 | |
| Pharmacovigilance in Gerontopsychiatric Patients Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression | Phase 3 | Terminated | Hannover Medical School | 407 | 2015-01-01 | 2018-02-28 |
| Zaleplon in HIV Patients With Depression Zaleplon - HIV/AIDS, Clinical Depression | Phase 2 | Completed | University of Pennsylvania | 20 | 2014-04-03 | 2018-10-16 |
| Optimize Astronaut Sleep Medication Efficacy and Individual Effects Zolpidem - Sleep, Cognition | Phase 4 | Completed | National Aeronautics and Space Administration (NASA) | 34 | 2011-01-10 | 2018-05-16 |
| Hypnotic Medications and Memory: Effect of Drug Exposure During the Night zaleplon, zolpidem extended release, bedtime placebo - Sleep, Memory | Phase 4 | Completed | St. Luke's Hospital, Chesterfield, Missouri | 26 | 2010-10-01 | 2014-08-26 |
| Study of Sleep-maintenance Activity of 3 Doses of SKP-1041 placebo, SKP-1041 (experimental formulation of zaleplon) - Sleep Disorder, Primary Insomnia | Phase 2 | Completed | Somnus Therapeutics, Inc. | 67 | 2010-05-01 | 2013-02-01 |
| Zaleplon 10mg Capsules Under Fasting Conditions Zaleplon 10 mg Capsules, Sonata® 10 mg Capsules - Healthy | Phase 1 | Completed | Teva Pharmaceuticals USA | 40 | 2004-02-01 | 2024-08-21 |
| Zaleplon 10 mg Capsules Under Non-Fasting Conditions Zaleplon 10 mg Capsules, SONATA® 10 mg capsules - Healthy | Phase 1 | Completed | Teva Pharmaceuticals USA | 42 | 2004-02-01 | 2024-08-21 |
| Bioequivalency Study of Zaleplon 10 mg Capsules Under Fed Conditions Zaleplon - Short Term Treatment of Insomnia | Not applicable | Completed | Roxane Laboratories | 40 | 2004-02-01 | 2018-01-23 |
| Bioequivalency Study of Zaleplon 10 mg Capsules Under Fasting Conditions Zaleplon - Short Term Treatment of Insomnia | Not applicable | Completed | Roxane Laboratories | 39 | 2004-01-01 | 2018-01-23 |
Sleep Initiation and Maintenance Disorders (2) · Acquired Immunodeficiency Syndrome (1) · Anxiety Disorders (1) · Dementia (1) · Depression (1) · Depressive Disorder, Major (1) · Neoplasms (1) · Psychophysiologic Disorders (1) · Schizophrenia (1) · Sleep Wake Disorders (1)
Roxane Laboratories (2) · Teva Pharmaceuticals USA (2) · University of Rochester (2) · Hannover Medical School (1) · National Aeronautics and Space Administration (NASA) (1) · Somnus Therapeutics, Inc. (1) · St. Luke's Hospital, Chesterfield, Missouri (1) · University of California, San Diego (1) · University of Pennsylvania (1)
United States (9) · Germany (1)
So Ran Hong, M.D. (4) · Kah Poh Loh (2) · Beth E. Safirstein, MD (1) · D. Alan Lankford, PhD (1) · David Dinges, PhD (1) · David J. Seiden, MD (1) · Helene A. Emsellem, MD (1) · Helge Frieling, Prof., MD (1) · James K. Walsh, PhD (1) · Janine M Hall-Porter, PhD (1) · Jon Freeman, PhD (1) · Matthew Kayser, MD, PhD (1) · Russell Rosenberg, PhD (1) · Smith Johnston, MD (1) · Steven G. Hull, MD (1)